ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,505.00
-0.71%
US Tech 100
19,000.00
-0.94%
Dow Jones
40,287.53
-0.93%
Brent Oil
82.285
0.01%
Bitcoin
67,726.05
-0.63%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Cytrx Corp. (MM) (CYTR)

  7. Cytrx Corp. (MM) (CYTR) News

CYTR

Cytrx (CYTR)

Cytrx Corp. (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CYTR
DateTimeSourceHeadlineSymbolCompany
12/19/20196:05AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CYTRCytrx Corp. (MM)
12/17/20192:23PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CYTRCytrx Corp. (MM)
12/17/20192:20PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CYTRCytrx Corp. (MM)
12/17/20192:19PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CYTRCytrx Corp. (MM)
12/17/20192:18PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CYTRCytrx Corp. (MM)
12/17/20192:17PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CYTRCytrx Corp. (MM)
11/15/20195:10PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CYTRCytrx Corp. (MM)
11/14/20196:15AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CYTRCytrx Corp. (MM)
08/29/20193:13PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CYTRCytrx Corp. (MM)
08/09/20196:17AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CYTRCytrx Corp. (MM)
08/01/20194:15PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CYTRCytrx Corp. (MM)
08/01/20194:14PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CYTRCytrx Corp. (MM)
06/26/20199:01AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CYTRCytrx Corp. (MM)
06/26/20196:16AMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:CYTRCytrx Corp. (MM)
06/24/20199:38AMEdgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:CYTRCytrx Corp. (MM)
06/06/20194:35PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CYTRCytrx Corp. (MM)
05/31/20199:01AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CYTRCytrx Corp. (MM)
05/31/20199:00AMPR Newswire (US)CytRx Corporation to Commence Trading on OTCQB Venture MarketNASDAQ:CYTRCytrx Corp. (MM)
05/15/20199:02AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CYTRCytrx Corp. (MM)
05/15/20199:00AMPR Newswire (US)CytRx Corporation Reports First Quarter 2019 Financial ResultsNASDAQ:CYTRCytrx Corp. (MM)
05/08/20199:00AMPR Newswire (US)CytRx Corporation Highlights Patent Issued for Use of Aldoxorubicin in the Treatment of Brain CancerNASDAQ:CYTRCytrx Corp. (MM)
05/02/20199:00AMPR Newswire (US)CytRx Corporation Highlights Arimoclomol Clinical Milestone Guidance Provided by Licensee Orphazyme A/SNASDAQ:CYTRCytrx Corp. (MM)
04/29/20199:00AMPR Newswire (US)CytRx Corporation Highlights Enrollment Completion in Phase 2/3 Clinical Trial of Sporadic Inclusion Body Myositis Conducted ...NASDAQ:CYTRCytrx Corp. (MM)
03/29/20199:00AMPR Newswire (US)CytRx Corporation Reports 2018 Financial ResultsNASDAQ:CYTRCytrx Corp. (MM)
03/29/20196:22AMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:CYTRCytrx Corp. (MM)
03/12/20199:00AMPR Newswire (US)CytRx Corporation's Subsidiary, Centurion BioPharma Corporation's Albumin Companion Diagnostic (ACDx), Could Be The First To ...NASDAQ:CYTRCytrx Corp. (MM)
02/13/20199:00AMPR Newswire (US)CytRx Corporation Leads Revival of Cytotoxic Therapies with LADR™ Technology Targeting Delivery Directly to the TumorNASDAQ:CYTRCytrx Corp. (MM)
02/11/20199:00AMPR Newswire (US)CytRx Corporation Highlights Majority of Cancer Patients Do Not Have Targetable Genetic Mutations and Are Therefore Candidate...NASDAQ:CYTRCytrx Corp. (MM)
02/06/20199:00AMPR Newswire (US)CytRx Corporation Highlights Positive Results from Full Data Set of Phase 2/3 Clinical Trial in Niemann Pick Disease Type C (...NASDAQ:CYTRCytrx Corp. (MM)
01/15/20196:21AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CYTRCytrx Corp. (MM)
 Showing the most relevant articles for your search:NASDAQ:CYTR

Your Recent History

USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
BIEL
Bioelectronics (PK)
USOTC
HIRU
Hiru (PK)
USOTC
SPZI
Spooz (PK)
USOTC
RONN
Ronn Motor (PK)
COIN
BTCUSD
Bitcoin
USOTC
VPLM
Voip Pal Com (QB)
NASDAQ
AVXL
Anavex Life Sciences
NASDAQ
COOP
Mr Cooper
USOTC
KEGS
1812 Brewing (PK)
NASDAQ
LWLG
Lightwave Logic
USOTC
DBMM
Digital Brand Media and ... (PK)
USOTC
NWBO
Northwest Biotherapeutics (QB)
NASDAQ
AMRN
Amarin
USOTC
IGPK
Intergrated Cannabis Sol... (PK)
USOTC
NSAV
Net Savings Link (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved